Coptis polysaccharide and application thereof in aspect of oral products such as toothpaste
Through dilute sulfuric acid extraction and cation exchange resin treatment, berberine polysaccharide was prepared, combined with components such as mannose, and the problem of bitter taste of berberine was solved, achieving significant effect and high activity of berberine polysaccharide in oral products such as toothpaste.
Patent Information
- Application Number
- CN202410951470.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2024-11-22
AI Technical Summary
The application of berberine in oral products such as toothpaste is limited by its bitter taste and is difficult to use widely. The existing Chinese herbal toothpaste is not versatile enough.
Coptis chinensis is soaked in dilute sulfuric acid, filtered after neutralization, and precipitated with cation exchange resin and ethanol to prepare polysaccharides. Combined with mannose, rhamnosaccharides and other ingredients to form acidic polysaccharides, reducing the bitter taste of the alkaloids of berberine while maintaining antibacterial and anti-inflammatory. active.
It significantly reduces the bitter taste of berberine alkaloids, improves the taste, and maintains the antibacterial and anti-inflammatory activity of berberine, making berberine polysaccharides have significant effects in oral products such as toothpaste.
Smart Images

Figure CN118994426A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of coptis chinensis, and particularly relates to coptis chinensis polysaccharide and application thereof in oral products such as toothpaste. Background Art
[0002] In 2022, the domestic market sales volume of toothpaste will be 449,000 tons, and the national sales volume of toothpaste will be 32 billion yuan, with functional toothpaste accounting for 80.1% of the market share (Xu Chunsheng, Analysis of the impact of new regulations on the toothpaste market and countermeasures. Oral Care Products Industry, V33(5):4, 2023.). Chinese herbal medicine in toothpaste has the functions of clearing heat, antibacterial, anti-inflammatory, eliminating bad breath, preventing caries and decay, stopping bleeding, desensitizing and relieving pain, etc., which is the main direction of toothpaste development (He Qingui. Current status of the application of Chinese herbal medicine in toothpaste. Toothpaste Industry. 2006, (4): 42-45).
[0003] Coptis chinensis is bitter and cold in nature. It has the functions of clearing away heat, drying dampness, purging fire and detoxifying. Coptis chinensis was first recorded as a medicine in Shennong's Herbal Classic and was listed as a top grade. The earliest record of Coptis chinensis treating "mouth sores" was in Mingyi Bielu (220-450 AD) (Coptis chinensis... mainly treats the cold and heat of the five internal organs,..., treats mouth sores...). Since then, all the monographs of traditional Chinese medicine in successive dynasties have detailed records of Coptis chinensis treating oral diseases. Compendium of Materia Medica (1578 AD) records that Coptis chinensis mainly treats "toothache" (apply Coptis chinensis powder to the painful area), "mouth sores" (decoct Coptis chinensis in wine and gargle from time to time) and "children's oral thrush (oral ulcers)" (use Coptis chinensis and aloe vera, equal parts of powder), etc. It can be seen that Coptis chinensis not only treats toothache, but also treats various oral diseases such as oral ulcers. A systematic study of the Chinese herbal toothpastes currently on the market shows that the Chinese herbal medicines for treating "toothache" include Rhizoma Zanthoxylum, and those for treating "oral ulcers" include Andrographis paniculata and Xiguashuang, while only Coptis chinensis can treat both toothache and oral ulcers. Therefore, Coptis chinensis is used in the production of oral products such as Coptis chinensis toothpaste and mouthwash with functional effects, and the effect is very obvious. However, Coptis chinensis tastes extremely bitter, which seriously restricts its application in oral products. Summary of the invention
[0004] In order to solve the problems in the prior art, the present invention provides a coptis chinensis polysaccharide and its application in oral products such as toothpaste, so as to achieve the purpose that the coptis chinensis polysaccharide has a significant effect in oral products such as toothpaste, does not affect the antibacterial and anti-inflammatory activity of coptis chinensis alkaloids, but can significantly reduce the bitterness of coptis chinensis alkaloids.
[0005] The present invention solves the technical problem by adopting the following technical solutions:
[0006] The present invention aims to provide a coptis chinensis polysaccharide, the preparation method of which comprises the following steps:
[0007] S1: preparing extract I, soaking and extracting Coptis chinensis with dilute sulfuric acid, neutralizing the extract with lime to make it weakly acidic, and filtering; adding sodium chloride salt to the filtrate, stirring, and filtering to obtain extract I;
[0008] S2: Preparation of Coptis chinensis polysaccharide: extract I is dissolved in water, passed through a cation exchange resin, the solution is filtered out, and concentrated under reduced pressure. Ethanol is added to the concentrate, and the precipitate is collected to obtain Coptis chinensis polysaccharide (HLP).
[0009] Further, in S1, Coptis chinensis is soaked in 10 times the amount of 0.25% sulfuric acid solution (V / V) for 24 hours and filtered; the residue is soaked in 10 times the amount of 0.25% sulfuric acid solution (V / V) for 24 hours and filtered; the filtrates are combined, the pH of the solution is adjusted to between 3 and 5 with lime, and filtered; sodium chloride is added to the filtrate to 20%, stirred evenly, left for 24 hours, and filtered; extract I is obtained.
[0010] Further, in S2, extract I is dissolved in 10 times distilled water and passed through a cation exchange resin at a loading amount of 2%; the filtrate is concentrated under reduced pressure to 1 g extract I / mL, ethanol is added and stirred for extraction, the ethanol concentration is controlled to 80%, and filtered; the precipitate is dried at low temperature to obtain Coptis chinensis polysaccharide.
[0011] Furthermore, the coptis chinensis polysaccharide is composed of mannose: rhamnose: glucuronic acid: galacturonic acid: glucose: galactose: arabinose = 0.46: 0.20: 0.07: 10.3: 37.6: 0.79: 15.00, and has a molecular weight of 3440 (Mw).
[0012] The invention discloses an application of coptis chinensis polysaccharide in preparing toothpaste and other oral products. Oral products include toothpaste, tooth powder, mouthwash, dentifrice, chewing gum and the like.
[0013] Compared with the prior art, the beneficial technical effects of the present invention are:
[0014] 1. The coptis chinensis polysaccharide (HLP) obtained by the present invention is an acidic polysaccharide component (containing a large amount of galacturonic acid) contained in coptis chinensis itself. After being compounded with coptis chinensis and coptis chinensis alkaloids, it does not affect the antibacterial and anti-inflammatory activities of coptis chinensis alkaloids, but can greatly reduce the bitterness of coptis chinensis alkaloids.
[0015] 2. The coptis chinensis polysaccharide obtained by the present invention can be used in toothpaste and other oral products in the form of an extract, has high antibacterial and anti-inflammatory activities and good taste.
[0016] The above description is only an overview of the technical solution of the present invention. In order to more clearly understand the technical means of the present invention, it can be implemented according to the contents of the specification. In order to make the above contents of the present invention and its objectives, features and advantages more obvious and easy to understand, the specific implementation methods of the present invention are listed below. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Figure 1 The figure is the GPC spectrum of the coptis chinensis polysaccharide HLP of the present invention.
[0018] Figure 2 The HPLC spectrum of the HLP monosaccharide derivatization of the Coptis chinensis polysaccharide of the present invention. DETAILED DESCRIPTION
[0019] The technical solution of the present invention is further described in detail below in conjunction with specific embodiments. It should be understood that the following embodiments are only exemplary illustrations and explanations of the present invention and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are included in the scope that the present invention is intended to protect.
[0020] In addition, unless otherwise specified, various raw materials, reagents, instruments and equipment used in the present invention can be purchased from the market or prepared by existing methods.
[0021] Example 1
[0022] 1) Preparation of crude extract of Coptis chinensis: 1000 g of Coptis chinensis was soaked in 10 liters of 0.25% sulfuric acid solution (V / V) for 24 hours and filtered; the residue was soaked in 10 liters of 0.25% sulfuric acid solution (V / V) for 24 hours and filtered; the filtrates were combined, the pH of the solution was adjusted to 4 with lime, and filtered; sodium chloride was added to the filtrate to 20%, stirred evenly, left for 24 hours, and filtered; extract I (150 g) was obtained.
[0023] 2) Preparation of Coptis chinensis polysaccharide: 150g of extract I was dissolved in 1500mL of distilled water and passed through 7500g001 cation exchange resin at a loading rate of 2%; the filtrate was concentrated to 150mL under reduced pressure, ethanol was added and stirred for extraction, the ethanol concentration was controlled to be 80%, and filtered; the precipitate was dried at low temperature to obtain Coptis chinensis polysaccharide HLP.
[0024] Experimental Example 1: HLP molecular weight and molecular composition analysis
[0025] 1. Experimental Materials
[0026] The Coptis chinensis polysaccharide HLP was prepared under the conditions of Example 1.
[0027] 2. Experimental methods and results
[0028] Determination of HLP purity and molecular weight: HLP was subjected to GPC test and only one peak appeared (see attached Figure 1 ), indicating that the obtained HLP is pure, and its molecular weight is 3440 (Mw). Figure 1 shown.
[0029] Determination of monosaccharide composition in HLP molecule: HLP was subjected to polysaccharide hydrolysis and derivatization, and then HPLC analysis was performed and compared with the standard. It was found that HLP was composed of mannose: rhamnose: glucuronic acid: galacturonic acid: glucose: galactose: arabinose = 0.46: 0.20: 0.07: 10.3: 37.6: 0.79: 15.00, as shown in the attached Figure 2 shown.
[0030] HLP does not contain protein and is an acidic polysaccharide with a molecular weight of 3440.
[0031] Test Example 2: Taste (bitterness) test of the compound of Coptis chinensis polysaccharide and extract
[0032] 1. Experimental Materials
[0033] Experimental drug 1: Coptis chinensis extract I prepared according to the conditions of Example 1.
[0034] Experimental drug 2: Coptis chinensis polysaccharide HLP prepared according to the conditions of Example 1.
[0035] Test drug 3: Coptis chinensis extract I: HLP = 1:0.1.
[0036] Experimental drug 4: Coptis chinensis extract I: HLP = 1:1.
[0037] Experimental drug 5: Coptis chinensis extract I: HLP = 1:10.
[0038] Experimental drug 6: Coptis chinensis extract I: glucose = 1:10.
[0039] Test drug 7: Coptis chinensis extract I: sucrose = 1:10.
[0040] Experimental drug 8: Coptis chinensis extract I: galacturonic acid = 1:10.
[0041] 2. Experimental methods
[0042] After the relevant drugs are compounded, they are prepared into a 1% aqueous solution and the bitter taste is tasted with the tongue.
[0043] 3. Experimental results
[0044] Table 1 Bitter taste results
[0045] Group Taste Trial drug 1 Very bitter Trial drug 2 Sweet Trial drug 3 Bitter Trial drug 4 Slightly bitter Trial drug 5 No bitter taste Trial drug 6 Slightly bitter Experimental drug 7 Slightly bitter Experimental drug 8 Slightly bitter
[0046] The experimental results in Table 1 show that the extract of Coptis chinensis tastes extremely bitter, and its bitterness is heavier than that of Coptis chinensis due to the increase in the concentration of Coptis chinensis alkaloids; Coptis chinensis polysaccharide, due to the absence of Coptis chinensis alkaloids, has a significant sweetness; after the Coptis chinensis polysaccharide is compounded with the extract, the bitterness gradually disappears with the increase in the amount of Coptis chinensis polysaccharide added, and when added to 1:10, the bitterness of the complex disappears; the same amount of glucose, sucrose and galacturonic acid cannot eliminate the bitterness of Coptis chinensis and its products. It can be seen that Coptis chinensis polysaccharide has a good effect of eliminating the bitterness of Coptis chinensis, which may be related to the fact that the Coptis chinensis polysaccharide prepared by this process is an acidic polysaccharide macromolecule, which forms a complex salt (acid-base salt formation) with Coptis chinensis alkaloids; while small molecular acidic sugars (such as galacturonic acid) cannot form an "embedded" complex salt with Coptis chinensis alkaloids, so although it also has a certain effect of masking bitterness, its effect is significantly lower than that of Coptis chinensis polysaccharide HLP.
[0047] Test Example 3: Antibacterial test of composite materials
[0048] 1. Experimental Materials
[0049] Experimental drug 1: Coptis chinensis extract I prepared according to the conditions of Example 1.
[0050] Experimental drug 2: Coptis chinensis polysaccharide HLP prepared according to the conditions of Example 1.
[0051] Test drug 3: Coptis chinensis extract I: HLP = 1:0.1.
[0052] Experimental drug 4: Coptis chinensis extract I: HLP = 1:1.
[0053] Experimental drug 5: Coptis chinensis extract I: HLP = 1:10.
[0054] 2. Experimental methods
[0055] Test method: Staphylococcus aureus, Escherichia coli, Proteus, and Porphyromonas gingivalis were selected as bacteria, and the experimental method was the paper disc method (Ma Xurong et al. Manual of Drug Microbiology Experiment [M]. Beijing: People's Medical Publishing House. 2001): The bacteria were first cultured on a slant medium at 37°C for 24 hours, and then two rings were taken and cultured in a broth medium for 6-8 hours. The count was observed under a microscope and adjusted to contain 105-106 / ml of bacteria for use. The experimental drug and the control drug were prepared into a 1% solution with normal saline (the concentration of Coptis chinensis extract I was kept at 1%) (1g toothpaste was added with 10mL normal saline), and the supernatant was taken after sufficient stirring and set aside. Sterile agar culture medium was poured into a 9cm glass plate, 12ml each, and set aside; 5mm diameter round paper discs were sterilized and soaked in the drug solution for use. 50μl of bacterial solution was evenly spread on the surface of the agar culture medium, and then the drug-containing paper disc was attached to the agar surface. After culturing at 37°C for 24 hours, the diameter of the inhibition zone was measured. Three patches were applied for each drug concentration. The average value was taken. The larger the diameter of the inhibition zone, the stronger the antibacterial ability. The results are shown in Table 2.
[0056] Table 2 Antibacterial test results (diameter of antibacterial circle, mm)
[0057] Staphylococcus aureus Escherichia coli Proteus Porphyromonas gingivalis blank 5.0±0.1 5.0±0.1 5.0±0.2 5.0±0.1 Test Example 1 21.3±3.4 20.2±2.1 24.3±2.5 22.4±2.9 Test Example 2 21.5±3.3 20.5±2.6 24.5±2.4 22.3±2.7 Test Example 3 21.2±2.5 20.3±2.2 24.3±2.5 22.6±2.1 Test Example 4 21.4±2.6 20.3±1.9 24.4±2.4 22.5±2.6 Test Example 5 21.2±3.5 20.4±2.1 24.2±2.1 22.4±2.7
[0058] From Table 2, we can see that the blank group is full of bacteria; around each drug group, bacteria cannot grow because the drug permeates around the paper. The larger the "circle" without bacteria, the more obvious the antibacterial effect. By comparison, we can find that each drug group contains the same concentration of extract I. Although the amount of HLP added varies greatly, it does not affect the antibacterial effect of the HLP extract.
[0059] Test Example 4: Anti-inflammatory test of the compound
[0060] 1. Experimental Materials
[0061] Experimental drug 1: Coptis chinensis extract I prepared according to the conditions of Example 1.
[0062] Experimental drug 2: Coptis chinensis polysaccharide HLP prepared according to the conditions of Example 1.
[0063] Test drug 3: Coptis chinensis extract I: HLP = 1:0.1.
[0064] Experimental drug 4: Coptis chinensis extract I: HLP = 1:1.
[0065] Experimental drug 5: Coptis chinensis extract I: HLP = 1:10.
[0066] 2. Anti-inflammatory test methods
[0067] Experimental method: Effect on xylene-induced ear edema in mice (Qin Xiulan et al., Experimental study on the analgesic and anti-inflammatory effects of Huanglian Jiedu Decoction, Chinese Pharmacology and Clinical Medicine, (6): 9, 1994): The experimental animals were grouped and administered the same dosage (same as Huanglian extract I), and each mouse was orally administered 0.3 mL for three consecutive days. One hour after administration on the third day, xylene was applied to the front and back surfaces of the left ears of each group of mice, and the mice were killed 30 minutes later. The left and right ears of each mouse were cut off, and a piece of the same size was taken from the same part of the left and right ears with a 9mm diameter puncher, and weighed. The difference in weight between the left and right ear pieces was taken as the degree of swelling; the results are shown in Table 3;
[0068] Table 3 Anti-inflammatory test results
[0069] Dosage (g / Kg) Ear swelling (mg) blank 3.68±1.09 Test Example 1 1.0 <![CDATA[2.12±0.72 ** ]]> Test Example 2 1.0 <![CDATA[2.17±0.63 * ]]> Test Example 3 1.0 <![CDATA[2.18±0.82 * ]]> Test Example 4 1.0 <![CDATA[2.11±0.73 * ]]> Test Example 5 1.0 <![CDATA[2.11±0.83 * ]]>
[0070] Note: *, △P≤0.05; **, △P≤0.01
[0071] As can be seen from Table 3, the ears of the blank group test mice were the heaviest and the most swollen; compared with the blank group, the ear weights of the test mice in each drug group decreased to varying degrees, indicating that they all had anti-inflammatory effects. By comparison, it can be found that each drug group contains the same concentration of extract I, and although the amount of coptis chinensis polysaccharide (HLP) added varies greatly, it does not affect the anti-inflammatory effect of the coptis chinensis extract.
[0072] The serial numbers of the above embodiments of the present invention are only for description and do not represent the advantages or disadvantages of the embodiments.
[0073] The embodiments of the present invention are described above in conjunction with the accompanying drawings, but the present invention is not limited to the above-mentioned specific implementation modes, which are merely illustrative rather than restrictive. Under the guidance of the present invention, ordinary technicians in this field can also make many forms without departing from the scope of protection of the present invention and the claims, all of which are within the protection of the present invention.
Claims
1. A coptis chinensis polysaccharide, characterized in that: The preparation method of coptis chinensis polysaccharide comprises the following steps: S1: preparing extract I, soaking and extracting Coptis chinensis with dilute sulfuric acid, neutralizing the extract with lime to make it weakly acidic, and filtering; adding sodium chloride salt to the filtrate, stirring, and filtering to obtain extract I; S2: preparing coptis chinensis polysaccharide, dissolving extract I in water, passing through a cation exchange resin, penetrating the liquid, concentrating under reduced pressure, adding ethanol to the concentrated liquid, and collecting the precipitate to obtain coptis chinensis polysaccharide.
2. The polysaccharide of Coptis chinensis according to claim 1, characterized in that: In S1, Coptis chinensis is soaked in 10 times the amount of 0.25% sulfuric acid solution for 24 hours and filtered; the residue is soaked in 10 times the amount of 0.25% sulfuric acid solution for 24 hours and filtered; the filtrates are combined, the pH value of the solution is adjusted to between 3 and 5 with lime, and filtered; sodium chloride is added to the filtrate to 20%, stirred evenly, left for 24 hours, and filtered; extract I is obtained.
3. The Rhizoma Coptidis polysaccharide according to claim 1, characterized in that: In S2, extract I is dissolved in 10 times distilled water and passed through a cation exchange resin at a loading amount of 2%; the filtrate is concentrated under reduced pressure to 1g extract I / mL, ethanol is added and stirred for extraction, the ethanol concentration is controlled to 80%, and filtered; the precipitate is dried to obtain Coptis chinensis polysaccharide.
4. The Rhizoma Coptidis polysaccharide according to claim 1, characterized in that: Coptis chinensis polysaccharide is composed of mannose: rhamnose: glucuronic acid: galacturonic acid: glucose: galactose: arabinose = 0.46: 0.20: 0.07: 10.3: 37.6: 0.79: 15.00, with a molecular weight of 3440.
5. Use of a coptis chinensis polysaccharide as claimed in any one of claims 1 to 4 in the preparation of oral products such as toothpaste.
